(Q53382756)

13 May 2018

title

Calcium-mediated transient phosphorylation of tau and amyloid precursor protein followed by intraneuronal amyloid-beta accumulation. (English)

1 reference

13 May 2018

1 reference

5

1 reference

13 May 2018

author name string

Nathalie Pierrot

1

1 reference

13 May 2018

Susana Ferrao Santos

2

1 reference

13 May 2018

Christine Feyt

3

1 reference

13 May 2018

Marina Morel

4

1 reference

13 May 2018

Jean-Noël Octave

6

1 reference

13 May 2018

language of work or name

English

0 references

publication date

3 November 2006

1 reference

13 May 2018

Journal of Biological Chemistry

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

13 May 2018

volume

281

1 reference

13 May 2018

issue

52

1 reference

13 May 2018

page(s)

39907-39914

1 reference

13 May 2018

Neuropathological stageing of Alzheimer-related changes

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Amyloid plaque core protein in Alzheimer disease and Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Alzheimer's disease: the amyloid cascade hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Intracellular amyloid-beta 1-42, but not extracellular soluble amyloid-beta peptides, induces neuronal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Intraneuronal amyloid-beta1-42 production triggered by sustained increase of cytosolic calcium concentration induces neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

The long term adenoviral expression of the human amyloid precursor protein shows different secretase activities in rat cortical neurons and astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Adenovirus-mediated transfer of a recombinant human alpha 1-antitrypsin cDNA to human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Progressive decrease of amyloid precursor protein carboxy terminal fragments (APP-CTFs), associated with tau pathology stages, in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Phosphoprotein phosphatase activities in Alzheimer disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Divergent roles of GSK3 and CDK5 in APP processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Regulation of amyloid precursor protein (APP) phosphorylation and processing by p35/Cdk5 and p25/Cdk5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Both N-methyl-D-aspartate (NMDA) and non-NMDA receptors mediate glutamate-induced cleavage of the cyclin-dependent kinase 5 (cdk5) activator p35 in cultured rat hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

The role of dihydropyridine-sensitive voltage-gated calcium channels in potassium-mediated neuronal survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Inhibitors of amyloid toxicity based on beta-sheet packing of Abeta40 and Abeta42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Neuron-specific phosphorylation of Alzheimer's beta-amyloid precursor protein by cyclin-dependent kinase 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

The role of the Cdk5-p35 kinase in neuronal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Neurotoxicity induces cleavage of p35 to p25 by calpain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

A brain-specific activator of cyclin-dependent kinase 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Fibroblast glutamate transport in aging and in AD: correlations with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Memantine: a therapeutic approach in treating Alzheimer's and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

Neuron loss in APP transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606015200

21 January 2018

Identifiers

DOI

10.1074/JBC.M606015200

1 reference

13 May 2018

1 reference

13 May 2018